CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Dermapharm Holding SE Company Snapshot
Dermapharm Holding SE operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dermapharm Holding SE with three other companies in this sector in GERMANY : Evotec SE (2019 sales of 446.44 million Euro [US$527.70 million] of which 76% was EVT Execute), Eckert & Ziegler Strahlen- und Medizinte (178.49 million Euro [US$210.98 million] of which 59% was Isotope Products), and Biotest AG (419.10 million Euro [US$495.39 million] of which 89% was Therapy).

Sales Analysis. Dermapharm Holding SE reported sales of 700.88 million Euro (US$828.46 million) for the year ending December of 2019. This represents an increase of 22.4% versus 2018, when the company's sales were 572.42 million Euro. This was the fourth straight year of sales growth at Dermapharm Holding SE. Sales of Pharmaceuticals and Other Products saw an increase of 15.1% in 2019, from 334.66 million Euro to 385.15 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Dermapharm Holding SE
  Stock Performance Chart for Dermapharm Holding SE
 
  Stock Data: Recent Stock Performance:
  Current Price (9/11/2020): 43.92
(Figures in Euros )
1 Week -1.8%   13 Weeks -2.4%  
4 Weeks 0.4%   52 Weeks 36.0%  
 
Dermapharm Holding SE Key Data:
  Ticker: DMP Country: Germany
  Exchanges: FRA Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 700,879,000
(Year Ending Jan 2020).
Employees: 1,853
  Currency: Euros Market Cap: 2,364,652,800
  Fiscal Yr Ends: December Shares Outstanding: 53,840,000
  Share Type: STAMMAKTIE Closely Held Shares: 40,406,920
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.